Roche, Novartis Medicines Delay Spread of Advanced Breast Cancer in Studies

Drugs from Roche Holding AG and Novartis AG (NOVN) that target different molecular drivers of breast cancer slowed tumor progression in separate studies that doctors say will change the way they care for patients.
Bloomberg